KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
KORU Medical Systems 2024年第一季度调整后每股收益美元（0.02）超过预期（0.04），销售额为819.8万美元，超过74.67亿美元的预期
KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 50 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $8.198 million which beat the analyst consensus estimate of $7.467 million by 9.80 percent. This is a 10.89 percent increase over sales of $7.393 million the same period last year.
KORU Medical Systems（纳斯达克股票代码：KRMD）公布的季度亏损为每股0.02美元，比分析师普遍预期的0.04美元（0.04美元）高出50％。这比去年同期每股亏损0.04美元（0.04）增加了50％。该公司公布的季度销售额为819.8万美元，比分析师普遍预期的746.7万美元高出9.80％。这比去年同期的739.3万美元的销售额增长了10.89％。